US Patent Issued to PROPHASE LABS on Aug. 5 for "Systems and methods for Barrett's esophagus pathogenesis and esophageal adenocarcinoma progression revealing markers" (New York Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,379,378, issued on Aug. 5, was assigned to PROPHASE LABS INC. (Garden City, N.Y.).

"Systems and methods for Barrett's esophagus pathogenesis and esophageal adenocarcinoma progression revealing markers" was invented by Joe Abdo (Garden City, N.Y.), Sumeet K. Mittal (Garden City, N.Y.) and Devendra K. Agrawal (Garden City, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods are provided for assessing risk of developing esophageal adenocarcinoma in a subject using one or more of the following marker genes/proteins: ISG15, LTF, CNDP2, DAD1, SET, UBE2N, S100P, and GPI. Methods are also provided for determining expression of one or more esophageal aden...